Details for New Drug Application (NDA): 040872
✉ Email this page to a colleague
NDA 040872 describes PHENTERMINE RESIN COMPLEX, which is a drug marketed by Lannett Co Inc and is included in one NDA. Additional details are available on the PHENTERMINE RESIN COMPLEX profile page.
The generic ingredient in PHENTERMINE RESIN COMPLEX is phentermine resin complex. There are seventeen drug master file entries for this compound. Additional details are available on the phentermine resin complex profile page.
The generic ingredient in PHENTERMINE RESIN COMPLEX is phentermine resin complex. There are seventeen drug master file entries for this compound. Additional details are available on the phentermine resin complex profile page.
Summary for 040872
| Tradename: | PHENTERMINE RESIN COMPLEX |
| Applicant: | Lannett Co Inc |
| Ingredient: | phentermine resin complex |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE, EXTENDED RELEASE;ORAL | Strength | EQ 15MG BASE | ||||
| Approval Date: | Jul 28, 2011 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE, EXTENDED RELEASE;ORAL | Strength | EQ 30MG BASE | ||||
| Approval Date: | Jul 28, 2011 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
